HU HU SHENG WEI capsules, 3000 mg, 2-count bottle, labeling is in foreign language
Published February 7, 2018 · Recall initiated: March 7, 2017
Summary
FDA records drug Class I recall D-0566-2018, published February 7, 2018 and initiated March 7, 2017. Recalling firm: A&H Focal Inc.; Status: Terminated; Reported quantity: unknown; Lot: All Lots. Class I means a reasonable probability of serious adverse health consequences or death.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Marked Without An Approved NDA/ANDA: FDA analysis found these products to contain sildenafil, an FDA approved drug for the treatment of erectile dysfunction, making these products unapproved drugs for which safety and efficacy have not been establish and therefore, subject to recall.
What to do
Voluntary: Firm initiated · Press Release
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- A&H Focal Inc.
- Distributor
- NY and NJ through six retail stores named "Asian Food Markets"
- Lot
- All Lots
- Risk classification
- Class I
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDALANG YI HAO CHAONONGSUOPIAN tablets, 500 mg, 8-count bottle, labeling is in foreign languageFebruary 7, 2018
- FDAYe Lang Shen capsules, 5000 mg, 8-count bottle, labeling is in foreign languageFebruary 7, 2018
- FDAIndian God Lotion Spray Bottle, labeling is in foreign languageFebruary 7, 2018
- FDAZhonghua Niubian tablets, 2000mg, 6-count bottle, labeling is in foreign languageFebruary 7, 2018
- FDAYANSHIJIAONANG capsules, 2000mg, 8-count bottle, labeling is in foreign languageFebruary 7, 2018
- FDAPower V8 Viagra tablets, 200mg, 10-Grain bottle, labeling is in foreign languageFebruary 7, 2018
Questions about this recall
Was HU HU SHENG WEI capsules, 3000 mg, 2-count bottle, labeling is in foreign language recalled?
Yes. FDA published recall D-0566-2018 on February 7, 2018. Reported hazard: Marked Without An Approved NDA/ANDA: FDA analysis found these products to contain sildenafil, an FDA approved drug for the treatment of erectile dysfunction, making these products unapproved drugs for which safety and efficacy have not been establish and therefore, subject to recall.
What should I do if I have this product?
Voluntary: Firm initiated · Press Release